Market closed
Enfusion/ENFN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Enfusion
Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. Its solutions are designed to eliminate technology and information barriers, empowering investment managers to make and execute an informed investment decisions in real-time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth. It generates maximum revenue from Americas, followed by Asia Pacific and Europe, Middle East, and Africa.
Ticker
ENFN
Sector
Trading on
NYSE
Industry
Software
Headquarters
Employees
1,102
Website
Enfusion Metrics
BasicAdvanced
$824M
Market cap
250.14
P/E ratio
$0.04
EPS
0.93
Beta
-
Dividend rate
Price and volume
Market cap
$824M
Beta
0.93
52-week high
$10.45
52-week low
$7.52
Average daily volume
342K
Financial strength
Current ratio
4.15
Quick ratio
3.811
Long term debt to equity
14.319
Total debt to equity
20.127
Management effectiveness
Return on assets (TTM)
3.74%
Return on equity (TTM)
6.62%
Valuation
Price to earnings (TTM)
250.141
Price to revenue (TTM)
4.189
Price to book
12.67
Price to tangible book (TTM)
12.67
Price to free cash flow (TTM)
45.913
Growth
Revenue change (TTM)
15.30%
Earnings per share change (TTM)
-47.84%
3-year revenue growth (CAGR)
26.41%
What the Analysts think about Enfusion
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Enfusion stock.
Enfusion Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Enfusion Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Enfusion News
AllArticlesVideos
Enfusion, Inc. Is Being Looked Into For Possible Securities Fraud And Affected Shareholders Are Urged To Contact The Schall Law Firm
Accesswire·3 weeks ago
The Schall Law Firm Invites Investors To Help Investigate Whether Enfusion Inc Violated Securities Laws
Accesswire·3 weeks ago
Shareholders Are Encouraged To Join The Schall Law Firm's Inquiry Into Enfusion, Inc. For Possible Securities Fraud
Accesswire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Enfusion stock?
Enfusion (ENFN) has a market cap of $824M as of October 24, 2024.
What is the P/E ratio for Enfusion stock?
The price to earnings (P/E) ratio for Enfusion (ENFN) stock is 250.14 as of October 24, 2024.
Does Enfusion stock pay dividends?
No, Enfusion (ENFN) stock does not pay dividends to its shareholders as of October 24, 2024.
When is the next Enfusion dividend payment date?
Enfusion (ENFN) stock does not pay dividends to its shareholders.
What is the beta indicator for Enfusion?
Enfusion (ENFN) has a beta rating of 0.93. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.